Is Georgia Tech or Boston University better for an undergraduate biotechnology major?

For an undergraduate aiming at engineering-intensive biotechnology, Georgia Tech is likely the more direct fit. Its strengths in chemical and biomolecular engineering, biomedical engineering, computing, and quantitative biology make it especially well suited to bioprocessing, synthetic biology, bioinformatics, medical devices, and translating research into scalable products.

Choose Georgia Tech if you want biotechnology training anchored in calculus, engineering design, programming, and process development. A student interested in designing a fermentation process, modeling biological systems, developing diagnostics, or working in biomanufacturing would benefit from its technical culture. Students should make sure their chosen major and electives leave room for substantial molecular biology and hands-on lab work.

Boston University may be more compelling for a student who wants biotechnology centered on molecular and cellular biology, biomedical research, and access to the Boston-Cambridge life-sciences ecosystem. Its proximity to major biotech employers, hospitals, research institutes, and startups can make semester internships, lab positions, and networking especially accessible.

BU is particularly appealing for someone considering drug discovery, genomics, immunology, translational medicine, or eventual graduate or professional school. Students will need to actively pursue research and internships rather than assume proximity alone produces opportunities.

For research careers, prioritize the school where you can join a lab early, build relationships with faculty, and take rigorous coursework in genetics, cell biology, biochemistry, statistics, and computation. For industry roles, Georgia Tech has the edge for engineering and manufacturing-oriented biotech, while BU offers unusually strong access to the research and startup side of the biotech industry.